Abstract
TWENTY-FIVE to thirty per cent of diabetic patients require insulin to remain alive and well. In the main these patients have the juvenile-onset type of diabetes mellitus and treatment for many years is normal. So far, the insulin they require can only be administered parenterally, despite many attempts in the past 40 years to circumvent the injections needed and the physical risks and psychological trauma involved1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lewis, J. J., Physiol. Rev., 29, 75 (1949).
Ferguson, E. A., U.S. Patent 3,172,814 (published March 9, 1965).
Nomenclature as per Smolin, E. M., and Rapoport, L., The Chemistry of Heterocyclic Compounds, 13 (Interscience Publishers, New York, 1959).
Miller, J., and Wagner, E., J. Amer. Chem. Soc., 54, 3698 (1932).
Winter, L. B., J. Physiol., 58, 18 (1923).
Hanzlik, P. J., and Cutting, W. C., Endocrinology, 28, 368 (1941).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
WALES, J., BRADLEY, P. & WOLFF, F. Oral Hypoglycaemic Activity of an Anhydroformaldehyde Aniline-Insulin Mixture. Nature 211, 88–89 (1966). https://doi.org/10.1038/211088a0
Issue Date:
DOI: https://doi.org/10.1038/211088a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.